VITASTEMVitaStem
$0.0128
$0.0002
(1.80%)
Mkt Cap$40,997.00
Vol18.44
<
...
1
>
Bullish/Bearish Forum Sentiment
Indicates whether most users posting on a crypto’s stream over the last 24 hours are bearish or bullish.
0
25
50
75
100
Extremely
Bearish
Neutral
Bullish
Extremely
Bearish
Bullish
N/A
Last score
N/A
1 day ago
Sign Up / Log In
1 week ago
Sign Up / Log In
1 month ago
Sign Up / Log In
3 months ago
Sign Up / Log In
6 months ago
Sign Up / Log In
1 year ago
Sign Up / Log In
Message Board Activity
Measures the total amount of chatter on a stream over the last 24 hours.
0
25
50
75
100
Extremely
Low
Normal
High
Extremely
Low
High
N/A
Last score
N/A
1 day ago
Sign Up / Log In
1 week ago
Sign Up / Log In
1 month ago
Sign Up / Log In
3 months ago
Sign Up / Log In
6 months ago
Sign Up / Log In
1 year ago
Sign Up / Log In
Discussion Diversity
Measures the number of unique accounts posting on a stream relative to the number of total messages on that stream.
0
25
50
75
100
Extremely
Low
Normal
High
Extremely
Low
High
N/A
Last score
N/A
1 day ago
Sign Up / Log In
1 week ago
Sign Up / Log In
1 month ago
Sign Up / Log In
3 months ago
Sign Up / Log In
6 months ago
Sign Up / Log In
1 year ago
Sign Up / Log In
AboutVitaSTEM — The first AI-enabled longevity project and inaugural IP-Token launched by Aubrai, VitaDAO’s decentralized scientific agent. After six months of deep research on public and proprietary single-cell RNA-seq and multi-omics datasets, our scientific research team analyzed more than 850,000 human hematopoietic stem cell transcriptomes from donors aged 23–91 (both male and female). This effort uncovered 100+ high-potential rejuvenation target genes and revealed critical drivers of decline such as RhoA hyperactivation, CD38 upregulation, and CCR9 downregulation. Rather than treating HSC aging as a single defect, Aubrai recognized it as convergent damage across interconnected systems, generating a comprehensive multi-modal, five-phase rejuvenation protocol targeting transcriptional stress, metabolic dysfunction, and epigenetic drift in parallel. The agent shortlisted target genes using insights from thousands of peer-reviewed publications and private data and also optimized experimental protocols to guide in vitro and upcoming pre-clinical testing. For the first time, human researchers and AI Agents collaborate as co-scientists in the creation of pioneering scientific IP.
DetailsCategories
Base EcosystemClanker EcosystemDecentralized Science (DeSci)
Date
Market Cap
Volume
Close
July 15, 2026
$40,996.82
$18.44
---
July 15, 2026
$41,486.37
$882.87
---
July 14, 2026
$46,481.10
$130.81
$0.0146
July 13, 2026
$48,064.17
$2.89
$0.0151
July 12, 2026
$48,602.68
$6.93
$0.0152
July 11, 2026
$48,678.27
$10.55
$0.0153
July 10, 2026
$47,972.10
$20.14
$0.015
July 09, 2026
$47,097.15
$61.83
$0.0148
July 08, 2026
$47,958.49
$370.43
$0.015
July 07, 2026
$50,630.38
$990.05
$0.0159